420 with CNW – California Audit Uncovers 3,000 Illegal Marijuana Businesses

An audit done by a marijuana business association has revealed that the number of black market cannabis industry players is thrice the number of the licensed marijuana businesses in the state.

The audit, whose findings were made public on Wednesday, indicates that there are 2,835 illegal marijuana businesses operating within California while the statistics from the Bureau of Cannabis Control show that only 873 companies are licensed to conduct marijuana-related business activities within the state.

This means that the number of illicit players dwarfs those who are within the licensed marijuana space. The audit was done by an industry group called the United Cannabis Business Association.

Their findings are the latest indicator of how rocky the marijuana industry in California is, even at a time when the state promised that it was going to crack the whip on the black market starting in 2018.

Earlier this year, a financial audit backed by industry players estimated that approximately $8.7 billion was lost to unlicensed cannabis products in the state while licensed businesses sold marijuana products worth only $3.1 billion.

Such information has led players in the legal marijuana industry to put their elected leaders, law enforcement and industry regulators on the spot for failing to curb the illicit trade of marijuana within the state.

This frustration with the slow progress in dealing with the marijuana black market has even prompted some licensed marijuana businesses in Los Angeles to recommend that tougher measures, such as prosecuting offenders in federal courts and incarcerating them thousands of miles away from their homes, could be tried to send a strong message that illegal commercial marijuana activities wouldn’t be tolerated or handled with kid gloves.

However, California’s marijuana industry isn’t faced with only the black market as a stumbling block. The industry is also grappling with the bans imposed on marijuana business operations by most of the local authorities.

The bans have put the state and the local authorities on a collision course since the state says that marijuana deliveries can be made anywhere within the state while the local authorities insist that the law allows them to either accept or ban marijuana companies from operating within their jurisdictions.

This conflict may also be fueling the marijuana black market since there are people who would wish to access marijuana in those areas where cannabis businesses aren’t allowed to operate, and where there is a need, supply will always show up one way or the other.

It isn’t clear what experienced industry actors like Neutra Corp. (OTCQB: NTRR) and Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) would propose as a comprehensive way to fix the major problems facing the largest marijuana market in the U.S.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsBreaks – Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) Receives Health Canada Approval to Bring Moncton Facility’s Annualized Licensed Capacity to 76,000 kg Target

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc., a leading licensed producer of cannabis, today announced its receipt of Health Canada approval, effective September 6, 2019, for the licensing of 17 additional cultivation rooms under the Cannabis Regulations. According to the update, the new cultivation rooms represent an increased target production capacity of approximately 15,000 kg per year. These are the company’s first 17 rooms licensed within its Phase 4B expansion and now brings its Moncton facility’s annualized licensed capacity to a target of 76,000 kg. “Once again, we are pleased to receive licensing approval consistent with our expectations and the streamlined process we have experienced to date,” Organigram CEO Greg Engel said in the news release. “Our Phase 4 facility expansion remains on schedule to meet growing demand and further contribute to efficiencies of scale.”

To view the full press release, visit http://cnw.fm/zkYp9

About Organigram Holdings Inc.

Organigram Holdings Inc. is a NASDAQ Global Select and TSX listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of cannabis and cannabis-derived products in Canada. Organigram is focused on producing high-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to extend the company’s global footprint. Organigram has also developed a portfolio of legal adult use recreational cannabis brands including The Edison Cannabis Company, Ankr Organics, Trailer Park Buds and Trailblazer. Organigram’s primary facility is located in Moncton, New Brunswick and the company is regulated by the Cannabis Act and the Cannabis Regulations (Canada). For more information, visit the company’s website at www.Organigram.ca.

* The forward looking estimate of target production capacity, once fully operational, is based on a number of material factors and assumptions. Please see the Company’s latest MD&A.

For more information, visit SEDAR at www.sedar.com and EDGAR at www.sec.gov

NOTE TO INVESTORS: The latest news and updates relating to OGI are available in the company’s newsroom at http://cnw.fm/OGI

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

420 with CNW – Israel to Triple Medical Marijuana Production

According to Israeli media, the government has issued an additional seven medical marijuana cultivation licenses. This decision will result in the tripling of the amount of medical marijuana grown in the country.

The seven companies granted cultivation licenses are Elpis Flora, Briev Agricultural Crops, Medical Cannabis Growing, Rami Sela, Shavit Agro, Natali Buskila and S. Sydan. It is expected that these seven entities will be in position to avail medical marijuana products to Israeli pharmacies by the end of this year.

This week also marks the overhaul of the medical marijuana program in Israel as new regulations come into force. These regulations require medical marijuana producers to sell their products to licensed medical marijuana pharmacies instead of selling those products directly to the certified patients. This move has added the layer of a middleman (the pharmacies) to the industry.

To make the transition smooth, regulators have said that starting with September, medical marijuana producers in the country will be expected to sell at least 10 percent of what they produce to pharmacies.

The volume sold to pharmacies must increase by 10 percent every month so that come January 2020, the entire volume of products grown by licensed cultivators is sold to pharmacies.

Medical marijuana patients and medical marijuana producers in the country have vehemently protested against these changes because the most likely outcome will be an increase in the price that patients have been paying for these products since pharmacies will add a markup to the price at which they buy the products from producers.

However, the government is adamant that the changes will go ahead because they want all products to go through an official distribution channel through which their quality can be checked to confirm that those products meet international standards.

True to the carrot and stick method of management, the government has dangled a juicy carrot to producers who make the necessary changes quickest. Those producers who are the fastest in selling all their products through pharmacies will be considered first when the country starts issuing medical marijuana export licenses.

That bait is irresistible because medical marijuana companies have been crying out for the process of issuing export licenses to be expedited. The companies know that with a limited Israeli population, long-term success can only come when they are allowed to access international markets.

President Reuven Rivlin has called a meeting this week in which the concerns of patients will be discussed so that the anticipated product shortages as strict standards are enforced so quickly can be minimized or avoided. Prime Minister Netanyahu will also attend that meeting.

At the moment, analysts believe that cannabis industry actors like Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) and Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) are hoping that their industry counterparts in Israel have a smooth transition to the new rules so that patients aren’t unnecessarily inconvenienced.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com